Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi (IST:ONCSM)

Turkey · Delayed Price · Currency is TRY

251.00

+7.00 (2.87%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions TRY. Fiscal year is January - December.

Millions TRY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Chemotherapy Drug Preparation Sets, Device Sales and Test Kit Sales	709.08M	490.18M	347.24M	292.94M	127.99M
Chemotherapy Drug Preparation Sets, Device Sales and Test Kit Sales Growth	44.66%	41.16%	18.54%	128.88%	-
Total	709.08M	490.18M	347.24M	292.94M	127.99M
Total Growth	44.66%	41.16%	18.54%	128.88%	-

Revenue by Geography

Financials in millions TRY. Fiscal year is January - December.

Millions TRY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Turkey	562.49M	477.30M	323.79M	258.09M	92.94M
Turkey Growth	17.85%	47.41%	25.46%	177.69%	-
Overseas	44.92M	11.53M	18.73M	27.40M	31.68M
Overseas Growth	289.52%	-38.42%	-31.64%	-13.53%	-
Unallocated	101.66M	1.35M	4.72M	7.45M	3.36M
Unallocated Growth	7440.15%	-71.41%	-36.70%	121.46%	-
Total	709.08M	490.18M	347.24M	292.94M	127.99M
Total Growth	44.66%	41.16%	18.54%	128.88%	-

Source: S&P Global Market Intelligence.